Neurotop® contains the active substance carbamazepine.
Carbamazepine has both a seizure-inhibiting and a mood-improving effect in various forms of epileptic seizures.
Neurotop® is given to adults, children and adolescents for the treatment of epilepsy.
Neurotop® can be used for monotherapy and combination therapy.
Neurotop® is used in adults for the treatment of acute mania and for the phase prophylaxis of manic-depressive psychoses in patients who do not respond to or for whom lithium therapy is contraindicated. Neurotop® is also used in trigeminal neuralgia, diabetic neuropathy and to prevent cerebral seizures in alcohol withdrawal syndrome.
|Strength||Pack size||Dosage form||Appearance|
|200 mg||50, 100||Tablets|
|400 mg||50, 100||Tablets|
|300 mg||50, 100||Prolonged-release tablets|
|600 mg||50, 100||Prolonged-release tablets|